Zwack Unicum Nyrt. Overview
Zwack Unicum is Hungary's largest branded spirits company and the custodian of Unicum, a bitter herbal liqueur widely regarded as one of Hungary's national drinks. The company is family-controlled and has been listed in Budapest since 1993. It combines two businesses. The first is a high-margin portfolio of its own brands: Unicum and its line extensions, St. Hubertus, Fütyülős, Kalumba gin, Vilmos, Kalinka and others. The second is a distribution arm that until 31 December 2026 holds the exclusive Hungarian mandate for Diageo's spirits. The model is asset-light and debt-free, and close to 100% of earnings are paid out as dividends. Domestic demand drives almost 90% of product revenue, so results are highly sensitive to Hungarian real wages, excise policy and retail-trade regulation. The defining event of 2026 is Diageo's decision to award its Hungarian distribution to another party. That decision removes about one-fifth of revenue and, by management's estimate, about 15% of profit from FY2028. Zwack's strategy is pivoting towards Unicum-led innovation, export growth and new third-party brands.
Company's own description
In its FY2026 and Q1 FY2027 management reports, the company describes its primary activity as the production and sale of branded premium and quality alcoholic drinks [S4]. It states that its principal aim is to defend its market-leading position in Hungarian spirits while strengthening its export markets. It also positions itself as the official domestic distributor of several international brands, chiefly the Diageo spirits portfolio. Combining its own brands (Unicum, Fütyülős, Kalumba, Vilmos, St. Hubertus, Kalinka) with global brands (Johnnie Walker, Baileys, Captain Morgan, Tanqueray, Smirnoff, Don Papa), it says, gives consumers an unusually broad choice [S4]. Management identifies product innovation and successful product launches as the key tools for defending its leadership. It also claims the largest sales and marketing workforce in the Hungarian spirits market [S3][S4].
Independent characterisation
Zwack is best understood as three interlocking economic engines.
-
Own-produced spirits (about 74% of FY2026 product revenue). This engine covers the Unicum brand family, the "quality" tier (St. Hubertus, Kalinka and others) and exports. It carries the margin. In Q1 FY2027 own-produced products generated HUF 1,002m of operating profit, against HUF 72m from traded products [S4]. Gross margin on the total business was 64.6% in FY2026, and the own-brand mix is what drives it [S1].
-
Third-party distribution (about 22% of FY2026 product revenue). This engine is predominantly Diageo, with smaller lines in mineral water (Evian), Prosecco and wines. It adds scale to the sales force, gives Zwack negotiating weight with retailers and on-trade customers, and supports the fixed cost base. Its stand-alone margins are thin and have sometimes been negative at quarterly level: traded products lost HUF 49m at the operating level in Q1 FY2026 [S4].
-
Services (about 4.5% of FY2026 revenue). This is mainly reimbursement from brand owners (Diageo Scotland Ltd.) for marketing that Zwack performs on their brands. It amounted to HUF 1,091m in FY2026 [S1].
Revenue model. Product sales account for about 95.5% of revenue and services/marketing reimbursements for about 4.5%. There is no subscription or licensing revenue.
Value-chain position. Zwack is vertically integrated in its own brands. It handles herbal maceration and distillation, cask ageing at Soroksári út, further ageing and bottling at Dunaharaszti, and fruit-brandy and gin distillation at Kecskemét. It then runs brand marketing and wholesale distribution in Hungary. For Diageo brands it acts as importer, wholesaler and marketing agent.
Customer types. Customers are Hungarian retail chains (off-trade), wholesalers that serve the on-trade (gastronomy), duty-free operators and foreign importers or distributors. Before COVID, the on-trade generated roughly half of domestic sales [S25]. Receivables are 95% credit-insured. The share of receivables held by the single largest counterparties (balances above 10%) was 19.4% at end-FY2026, down from 30.7% a year earlier [S1].
End-markets. About 90% of product revenue comes from Hungarian beverage-alcohol consumption [S4]. Exports go mainly to Italy, Germany, Romania and Slovakia, plus duty free, with smaller volumes to North America [S4].
Strategy
Stated strategic themes (latest reports, paraphrased)
-
Defend Hungarian market leadership in branded spirits through brand building, distribution strength and speed of innovation [S4].
-
Consumer-centred innovation around Unicum, extending the brand to new occasions and consumers without diluting its heritage. Sándor Zwack has publicly said that some flavours, such as a hypothetical mango Unicum, would clash with the brand's DNA [S44]. Recent execution includes Orange Bitter, Trezor XO, Sült Gesztenye and Kalumba RTD [S1][S4][S12].
-
Export expansion. After the Diageo loss, management describes exports as the deliberate focus, with domestic volume growth not expected [S7]. Priorities are a unified international Unicum communication platform and rolling out Orange Bitter abroad [S7].
-
Portfolio replacement. The company plans to offset the Diageo revenue gap through its own innovations and by adding new international brands to distribute [S6].
-
Sustainability and resilience. The company uses 100% green electricity, has made energy-efficiency investments, applies circular-economy principles, and published a sustainability report for FY2026 [S4].
-
Long-term family stewardship. Management repeatedly frames the company as a listed family business guided by tradition, innovation, business resilience and responsibility to employees [S2].
Initiatives announced in the last 24 months (Oct 2024 – Oct 2026)
| Initiative | Date | Description | Status / metric |
|---|---|---|---|
| Unicum Orange Bitter | On-trade autumn 2024; retail Apr 2025 | New flavour, launched on-trade first with minimal communication | Primary FY2026 growth driver; international rollout planned [S1][S7] |
| Unicum Trezor XO | FY2025 | 10-year-aged luxury edition in numbered bottles | Limited release continued in FY2026 [S2][S39] |
| Flavour extensions | FY2025 | St. Hubertus Blood Orange, Kalumba Maracuja, Fütyülős Tutti Frutti | Cited as successful [S2] |
| Museum enhancements | FY2025 | Immersive projection room; Trezor cellar experience | 30,000 visitors in FY2026 [S39] |
| Leadership renewal | 1 Jul 2025 | New CEO, CFO and Commercial Director | Organisational streamlining under way [S4] |
| Don Papa rum distribution | Jul 2025 | Diageo premium rum added to the distributed portfolio | Ends with the Diageo contract [S1] |
| Logistics cost programme | FY2026–FY2027 | Warehousing and freight services re-tendered | Freight and warehousing −7.4% (HUF 15m) in Q1 FY2027 [S4] |
| FX hedging policy | FY2026 | At least 50% of forecast FX purchases hedged against plan rate; hedge accounting applied for the first time | HUF 1,344m forwards outstanding at EUR/HUF 384 [S1] |
| Kalumba RTD | Q1 FY2027 | Entry into ready-to-drink cocktails | Contributed significantly to retail growth [S4] |
| Unicum Sült Gesztenye | 15 Oct 2026 | First seasonal Unicum (October–December) | Launch phase [S12] |
| Diageo replacement programme | From 23 Sep 2026 | Sourcing new international brands and developing own innovations | No partner announced as of the cut-off [S6] |
| Unicum Plum in Germany | 2,026 | Launch preparation reported by media | Unconfirmed timing [S37] |
Management guidance and medium-term targets
| Item | Guidance | Source |
|---|---|---|
| FY2027 profit after tax | About HUF 3.1bn, broadly in line with FY2026 | Management, July 2026 [S8] |
| FY2027 Diageo impact | Not material, because Zwack distributes Diageo for nine of twelve months, which historically account for about 85% of the portfolio's annual revenue | [S6][S29] |
| FY2028 onward | Profit could be about 15% below the current level because of the Diageo exit, before any offset from new brands | [S6] |
| Domestic volumes | No significant expansion expected in the near term | [S7] |
| Export share (legacy target) | 11% to 15% of product revenue within three years, set in FY2023; not achieved (10.3% in FY2026) | [S3][S1] |
Formal medium-term revenue or margin targets are not publicly disclosed. The company has not held an investor day.
Products & Services
Pricing is not disclosed in company filings. Brands are listed product by product, grouped by the company's product-group taxonomy.
Own-produced — Premium (Unicum family and premium brands)
| Brand / SKU | Description & key specifications | Target customer | Launch / latest version | Notes |
|---|---|---|---|---|
| Unicum (classic) | Bitter herbal liqueur macerated and distilled from more than 40 herbs and roots, then aged in oak casks. 40% ABV. The secret "heart" herb mix is known only to family members [S16][S36] | Core Hungarian adult consumers, digestif occasions, on-trade shots | Recipe 1790; commercial 1840 | Flagship. Unicum sales grew 10.6% in FY2025 and increased again in FY2026 [S2][S1] |
| Unicum Szilva (Plum) | Unicum finished on dried plums | Younger and broader consumers; exports including the US | US launch 2013 | Management said in 2026 it was preparing a launch in Germany [S16][S37] |
| Unicum Barista | Unicum blended with coffee | Younger consumers, cocktails and retail | Retail rollout FY2022 | Key driver of the FY2022 rebound [S27][S38] |
| Unicum Riserva | Super-premium, longer-aged expression | Premium and gifting segment | Jan 2017 | Revenue +26.3% in FY2025 [S2][S33] |
| Unicum Orange Bitter | Orange-flavoured Unicum variant | Younger, mixology-oriented consumers | On-trade autumn 2024; retail Apr 2025 | Main driver of FY2026 growth. Export rollout planned [S1][S7] |
| Unicum Trezor XO | Luxury herbal liqueur aged 10 years. Numbered bottles in very limited quantities, maturing in the "Trezor" cellar under seven padlocks | Luxury and collector segment | FY2025 launch; limited FY2026 introduction | Opens a "luxury herbal liqueur" category [S2][S39] |
| Unicum Sült Gesztenye (Roasted Chestnut) | Seasonal edition with roasted-chestnut notes and a finish in chestnut-wood casks. 30% ABV, 0.7 l, sleeve and neck-tag packaging, limited volumes, sold October–December only | Christmas and gifting season | 15 Oct 2026 | First purpose-designed seasonal Unicum in more than 230 years [S12] |
| Zwack (US-market liqueur) | Herbal liqueur sold in the US under the Zwack name | US consumers | 2,008 | Distributed via importers; volumes not disclosed [S16] |
| Kalumba (gin) | Craft-style gin brand whose original expression is Madagascar Spiced. Flavour extensions include mango, blood orange and maracuja | Gin-and-tonic consumers, younger adults | 2018/19; flavour extensions FY2023–FY2025 | Revenue +22.2% in FY2025. Management claims gin-segment leadership within five years of launch [S2][S40] |
| Kalumba RTD | Ready-to-drink cocktails and long drinks in several flavours | Convenience-led retail consumers | Q1 FY2027 (Apr–Jun 2026) | Contributed significantly to retail-channel growth in Q1 FY2027 [S4] |
| Fütyülős | Fruit spirit and liqueur family. Brand redesign 2018/19; Tutti Frutti flavour added in FY2025 | Mainstream domestic consumers | Long-standing; redesign 2018/19 | Classified in the premium category in company commentary; sales +17% in FY2023 [S3][S2] |
| Vilmos | Williams pear pálinka / fruit brandy | Pálinka connoisseurs | Long-standing | Listed among the company's premium brands [S3] |
| Zwack Sándor Nemes Pálinka | Premium fruit brandies | Connoisseurs, gifting | — | [S17-SWS][S21-OTP] |
| Zwack Maximillian | Premium spirit line | Premium consumers | — | [S21-OTP] |
Own-produced — Quality tier
| Brand | Description | Target customer | Notes |
|---|---|---|---|
| St. Hubertus | Herbal bitter liqueur at a mid-price point. Variants include Hubertus 33 and St. Hubertus Blood Orange (FY2025) | Mainstream bitter consumers | Revenue +8.6% in FY2025 and modest growth in FY2026. Growing in Q1 FY2027 [S2][S1][S4] |
| Kalinka | Vodka | Value-to-mainstream vodka consumers | Significant decline in FY2026, recovering in Q4 FY2026. International medals [S1][S2] |
| Kosher range | Kosher fruit brandies, e.g. Slivovitz 3-Year-Old Kosher at 47% ABV, sold in Canada (LCBO) | Kosher and export markets | [S41] |
| Other legacy brands | Hiros, Portorico, Lánchíd, ZIB (as listed by aggregators) | Value segments | Individual performance not disclosed [S17-SWS] |
Wines
| Line | Description | Notes |
|---|---|---|
| Izabella Zwack Wine Selection | Wines sourced in part from Dobogó Pincészet Kft., a Zwack-family-owned Tokaj winery and related party | Featured in annual reports [S2][S3] |
Traded / distributed brands (domestic)
| Principal | Brands (indicative, as disclosed) | Status |
|---|---|---|
| Diageo (exclusive spirits distributor since 1993; current contract framework since 1 July 2004) | Johnnie Walker, Baileys, Captain Morgan, Smirnoff, Tanqueray, Gordon's, Cîroc, Bulleit, Talisker, Caol Ila, The Singleton, Ron Zacapa, Black Velvet, Don Papa (from July 2025) and Diageo RTDs [S4][S17-SWS] | Ends 31 December 2026; Zwack lost the tender [S6] |
| Other principals | Evian mineral water, Prosecco, other wines and sparkling wines [S1][S17-SWS] | Revenue +13.5% in FY2026; +16.5% in Q1 FY2027 [S1][S4] |
Services
| Service | Description | FY2026 revenue |
|---|---|---|
| Marketing services to brand owners | Zwack runs marketing on distributed brands, reimbursed mainly by Diageo Scotland Ltd. | Total services revenue HUF 1,091m, of which HUF 949m was from Diageo Scotland [S1] |
| Unicum House (museum and visitor centre) | Brand-experience centre at the Soroksári út HQ with an immersive projection room and the Trezor cellar | Record 30,000 visitors in FY2026 versus 25,000 in FY2025 [S39][S2]. Revenue not separately disclosed |
Financial Narrative
Income statement: notes and sources
Sources: FY2023 IFRS [S3] for FY2022–FY2023; FY2025 Annual Report [S2] for FY2024–FY2025; FY2026 IFRS [S1]. Gross profit and EBITDA are analyst calculations; the company does not report EBITDA. Dividends are those approved by the AGM for each fiscal year [S1][S2][S3][S7].
Margins and growth (analyst calculation, %)
"n/d" = not derived. Revenue CAGR FY2022–FY2026: 7.5% per year (analyst calculation: 24,432 / 18,314 over 4 years). Net profit CAGR FY2022–FY2026: −0.2% per year.
Commentary — income statement.
Revenue: Revenue grew 33% over four years, but the path was uneven. FY2023 (+15.8%) benefited from price rises taken to pass on the July 2022 excise shock: average price increases of 7% in July 2022 and 5.6% in January 2023 [S3]. FY2024 and FY2025 grew 6–7%, again driven largely by price and mix, while volume fell 1% in FY2024 [S23]. FY2026 decelerated to +1.6%. Domestic own-brand revenue rose 4.4%, but services fell 18.3% as Diageo-funded marketing activity was reduced, and exports fell 5.1% [S1].
Gross margin: Gross margin dropped 4.3 percentage points in FY2023 because of raw-material inflation and a weak forint [S3]. It then recovered steadily to 64.6% in FY2026, above the pre-inflation level, helped by a richer own-brand mix (Orange Bitter, Riserva) and a modestly stronger forint [S1]. This is the single most positive structural trend in the numbers.
Operating cost inflation: Operating costs compressed operating margin from 19.9% to 14.9% between FY2022 and FY2025. Employee costs rose 56% over FY2022–FY2026, reflecting wage increases of about 10–12% a year, a one-off FY2025 provision of HUF 241m for notice-period pay to departing directors, and fair-value movements on the cash-settled liquidation-preference share plan [S1][S2][S3]. Other operating expenses rose 45%. Advertising rose from HUF 2,093m in FY2023 to HUF 2,885m in FY2025, and new regulatory charges were added: EPR fees from July 2023 and DRS-related costs [S1][S2]. FY2026 was the first year of operating leverage in the period, with operating profit up 8.8% on revenue up 1.6%, as cost growth was contained to +0.3% in aggregate [S1].
Net profit: Net profit peaked at HUF 3,448m in FY2023, helped by HUF 292m of interest income on deposits when Hungarian interest rates were high. FY2026's HUF 3,179m beat management's own plan and was 6.4% above FY2025 [S30].
Balance sheet
Sources: [S1][S2][S3]. Net debt and working capital are analyst calculations. Zwack has no borrowings. A HUF 1,250m short-term loan outstanding at 1 April 2021 was repaid during FY2022 [S3].
Commentary — balance sheet. The balance sheet is fortress-like but deliberately not over-capitalised. Equity has been held at roughly HUF 8.8–9.3bn because each year's profit is distributed the following summer. Cash sits at HUF 3.4–5.1bn, almost entirely in HUF term deposits [S1]. The company has HUF 7.3bn of undrawn committed bank facilities (Erste, K&H, UniCredit), of which HUF 2.14bn is overdraft [S1]. The only material off-balance-sheet item is HUF 1.4bn of bank guarantees issued as customs bonds for untaxed excise goods [S1].
The FY2023 inventory build, up HUF 1,377m (+44%), was a deliberate de-risking response to supply-chain disruption and raw-material inflation. It was unwound in FY2024 with an HUF 831m release, producing the FY2023 cash dip and the FY2024 cash-flow rebound [S2][S3]. Intangibles are negligible: there is no capitalised brand value, because the Unicum trademarks are internally generated and not recognised. Book value therefore understates economic value very substantially.
Cash flow
Sources: [S1][S2][S3]. FCF and conversion are analyst calculations. The company holds no treasury shares and has no buyback authorisation [S4].
Commentary — cash flow. Cumulative FCF for FY2022–FY2026 was HUF 13.3bn, against cumulative dividends of HUF 13.6bn. The company has effectively distributed all free cash generated, funding the small gap from opening cash. Capex intensity is low, at 2.9% of FY2026 revenue. The FY2023 peak of HUF 1.24bn reflected the energy projects at Dunaharaszti (geothermal, heat pump, solar) [S3]. The next notable item is a filling-machine replacement at Kecskemét costing HUF 209m, paid in Q1 FY2027 [S4].
Return and efficiency ratios (analyst calculation)
Commentary — ratios. ROE in the 32–40% range and ROIC above 50% are exceptional, and they reflect brand economics plus a negligible capital base. The modest ROE decline since FY2022 reflects margin compression, not balance-sheet dilution. The cash conversion cycle lengthened from about 74 days in FY2022 to about 99 days in FY2026, mainly through a shorter DPO. That is worth monitoring, but it is immaterial to liquidity.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Revenue by Segment
| Product group (HUF Mn) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Domestic own premium products (HUF Mn) | 8,677 | 9,611 | 10,400 | 11,479 | 12,258 |
Domestic own quality products (HUF Mn) | 2,868 | 3,326 | 3,648 | 3,631 | 3,518 |
Export own-produced products (HUF Mn) | 2,116 | 2,337 | 2,196 | 2,530 | 2,400 |
Traded products, domestic, mainly Diageo (HUF Mn) | 4,030 | 4,856 | 5,048 | 5,082 | 5,165 |
Total product revenue (HUF Mn) | 17,691 | 20,130 | 21,292 | 22,722 | 23,341 |
Services, mainly marketing reimbursements (HUF Mn) | 623 | 1,085 | 1,204 | 1,335 | 1,091 |
Total revenue (HUF Mn) | 18,314 | 21,215 | 22,496 | 24,057 | 24,432 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansProduct group YoY growth (%)
| Product group YoY growth (%) | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
Domestic own premium (%) | 10.8 | 8.2 | 10.4 | 6.8 |
Domestic own quality (%) | 16.0 | 9.7 | -0.5 | -3.1 |
Export own-produced (%) | 10.4 | -6.0 | 15.2 | -5.1 |
Traded, domestic (%) | 20.5 | 4.0 | 0.7 | 1.6 |
Total revenue (%) | 15.8 | 6.0 | 6.9 | 1.6 |
Share of product revenue (%)
| Share of product revenue (%) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Domestic own premium (%) | 49.0 | 47.7 | 48.8 | 50.5 | 52.5 |
Domestic own quality (%) | 16.2 | 16.5 | 17.1 | 16.0 | 15.1 |
Export own-produced (%) | 12.0 | 11.6 | 10.3 | 11.1 | 10.3 |
Traded, domestic (%) | 22.8 | 24.1 | 23.7 | 22.4 | 22.1 |
Q1 operating profit by product group (HUF Mn)
| Q1 operating profit by product group (HUF Mn) | Q1 FY2026 | Q1 FY2027 |
|---|---|---|
Own-produced products operating profit (HUF Mn) | 990 | 1,002 |
Traded products operating profit (HUF Mn) | -49 | 72 |
Services operating profit (HUF Mn) | 25 | 36 |
Total operating profit (HUF Mn) | 966 | 1,110 |
Q1 net sales by product group (HUF Mn)
| Q1 net sales by product group (HUF Mn) | Q1 FY2026 | Q1 FY2027 |
|---|---|---|
Own-produced products net sales (HUF Mn) | 4,621 | 4,537 |
Traded products net sales (HUF Mn) | 936 | 1,105 |
Services sales (HUF Mn) | 197 | 113 |
Total net sales (HUF Mn) | 5,754 | 5,755 |
Income Statement and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Gross sales incl. excise, NETA and DRS (HUF Mn) | 31,949 | 35,364 | 36,938 | 38,788 | 39,600 |
Revenue, net (HUF Mn) | 18,314 | 21,215 | 22,496 | 24,057 | 24,432 |
Material-type expenses (HUF Mn) | 6,561 | 8,511 | 8,949 | 8,805 | 8,641 |
Gross profit, revenue less material expenses (HUF Mn) | 11,753 | 12,704 | 13,547 | 15,252 | 15,791 |
Employee benefits expense (HUF Mn) | 3,150 | 3,685 | 4,146 | 4,862 | 4,899 |
Depreciation & amortisation (HUF Mn) | 596 | 600 | 629 | 635 | 693 |
Other operating expenses (HUF Mn) | 4,404 | 4,651 | 5,407 | 6,250 | 6,373 |
Other operating income (HUF Mn) | 50 | 100 | 101 | 78 | 72 |
Operating profit (HUF Mn) | 3,653 | 3,868 | 3,466 | 3,583 | 3,898 |
EBITDA, operating profit plus D&A (HUF Mn) | 4,249 | 4,468 | 4,095 | 4,218 | 4,591 |
Net financial income (HUF Mn) | 109 | 292 | 170 | 178 | 98 |
Profit before tax (HUF Mn) | 3,762 | 4,160 | 3,636 | 3,761 | 3,996 |
Income tax expense (HUF Mn) | 562 | 712 | 730 | 772 | 817 |
Net profit (HUF Mn) | 3,200 | 3,448 | 2,906 | 2,989 | 3,179 |
EPS basic, equal to diluted (HUF) | 1,600 | 1,724 | 1,453 | 1,495 | 1,590 |
Dividend per share for the fiscal year (HUF) | 1,500 | 1,700 | 1,400 | 1,500 | 1,550 |
Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue growth YoY (%) | — | 15.8 | 6.0 | 6.9 | 1.6 |
Gross margin (%) | 64.2 | 59.9 | 60.2 | 63.4 | 64.6 |
Operating margin (%) | 19.9 | 18.2 | 15.4 | 14.9 | 16.0 |
EBITDA margin (%) | 23.2 | 21.1 | 18.2 | 17.5 | 18.8 |
Pre-tax margin (%) | 20.5 | 19.6 | 16.2 | 15.6 | 16.4 |
Net margin (%) | 17.5 | 16.3 | 12.9 | 12.4 | 13.0 |
Effective tax rate incl. local business tax (%) | 14.9 | 17.1 | 20.1 | 20.5 | 20.4 |
Dividend payout ratio (%) | 93.8 | 98.6 | 96.4 | 100.4 | 97.5 |
Balance Sheet
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets (HUF Mn) | 15,092 | 15,433 | 14,963 | 15,067 | 15,588 |
Property, plant & equipment (HUF Mn) | 3,309 | 3,946 | 3,755 | 3,861 | 3,927 |
Intangible assets (HUF Mn) | 78 | 75 | 77 | 80 | 80 |
Goodwill (HUF Mn) | 0 | 0 | 0 | 0 | 0 |
Inventories (HUF Mn) | 3,140 | 4,517 | 3,686 | 3,750 | 3,886 |
Trade receivables (HUF Mn) | 3,198 | 3,149 | 3,433 | 3,247 | 3,372 |
Cash & cash equivalents, incl. term deposits (HUF Mn) | 5,079 | 3,433 | 3,622 | 3,636 | 3,835 |
Short-term bank debt (HUF Mn) | 0 | 0 | 0 | 0 | 0 |
Long-term bank debt (HUF Mn) | 0 | 0 | 0 | 0 | 0 |
Lease liabilities, total (HUF Mn) | 43 | 30 | 45 | 44 | 27 |
Net debt incl. leases; negative = net cash (HUF Mn) | -5,036 | -3,403 | -3,577 | -3,592 | -3,808 |
Total equity (HUF Mn) | 8,812 | 9,260 | 8,766 | 8,955 | 9,145 |
Total liabilities (HUF Mn) | 6,280 | 6,173 | 6,197 | 6,112 | 6,443 |
Current assets (HUF Mn) | 11,601 | 11,312 | 11,043 | 11,038 | 11,490 |
Current liabilities (HUF Mn) | 5,628 | 5,493 | 5,514 | 5,434 | 5,843 |
Working capital, current assets less current liabilities (HUF Mn) | 5,973 | 5,819 | 5,529 | 5,604 | 5,647 |
Cash Flow and Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Cash generated from operations (HUF Mn) | 4,372 | 2,889 | 4,681 | 4,145 | 4,509 |
Operating cash flow after interest and tax (HUF Mn) | 4,044 | 2,208 | 3,781 | 3,336 | 3,668 |
Capex: PPE plus intangibles (HUF Mn) | 473 | 1,238 | 532 | 775 | 711 |
Free cash flow, OCF minus capex (HUF Mn) | 3,571 | 970 | 3,249 | 2,561 | 2,957 |
Dividends paid (HUF Mn) | 1,400 | 3,000 | 3,400 | 2,800 | 3,000 |
Share buybacks (HUF Mn) | 0 | 0 | 0 | 0 | 0 |
FCF conversion of net profit (%) | 111.6 | 28.1 | 111.8 | 85.7 | 93.0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE on average equity (%) | 40.4 | 38.2 | 32.2 | 33.7 | 35.1 |
ROA on average assets (%) | 22.7 | 22.6 | 19.1 | 19.9 | 20.7 |
ROIC, NOPAT over year-end equity plus leases less cash (%) | 82.3 | 54.8 | 53.4 | 53.1 | 58.1 |
Current ratio (x) | 2.06 | 2.06 | 2.00 | 2.03 | 1.97 |
Debt to equity, leases only (x) | 0.005 | 0.003 | 0.005 | 0.005 | 0.003 |
Net debt to EBITDA (x) | -1.19 | -0.76 | -0.87 | -0.85 | -0.83 |
Interest coverage, operating profit over interest expense (x) | 228 | 3,868 | 81 | 1,792 | 80 |
Asset turnover, revenue over average assets (x) | 1.30 | 1.39 | 1.48 | 1.60 | 1.59 |
DSO on gross sales (days) | 36.5 | 32.5 | 33.9 | 30.6 | 31.1 |
DIO on material expenses (days) | 174.7 | 193.7 | 150.3 | 155.5 | 164.1 |
DPO, trade and other payables over material expenses (days) | 137.7 | 109.1 | 98.5 | 90.9 | 95.9 |
Cash conversion cycle (days) | 73.5 | 117.1 | 85.7 | 95.2 | 99.3 |
Revenue by Region
| Region (HUF Mn) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Hungary (HUF Mn) | 15,575 | 17,793 | 19,096 | 20,192 | 20,941 |
Europe excl. Hungary (HUF Mn) | 1,954 | 2,150 | 2,119 | 2,414 | 2,300 |
Other / rest of world (HUF Mn) | 162 | 187 | 77 | 116 | 100 |
Total product revenue (HUF Mn) | 17,691 | 20,130 | 21,292 | 22,722 | 23,341 |
Region YoY growth (%)
| Region YoY growth (%) | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
Hungary (%) | 14.2 | 7.3 | 5.7 | 3.7 |
Europe excl. Hungary (%) | 10.0 | -1.4 | 13.9 | -4.7 |
Other (%) | 15.4 | -58.8 | 50.6 | -13.8 |
Region share of product revenue (%)
| Region share of product revenue (%) | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Hungary (%) | 88.0 | 88.4 | 89.7 | 88.9 |
Europe excl. Hungary (%) | 11.0 | 10.7 | 10.0 | 10.6 |
Other (%) | 0.9 | 0.9 | 0.4 | 0.5 |
FY2026 product revenue (HUF Mn)
| FY2026 product revenue (HUF Mn) | Hungary | Abroad |
|---|---|---|
Own premium | 12,258 | — |
Own quality | 3,518 | — |
Own exports, all categories | 0 | 2,400 |
Traded | 5,165 | 0 |
Country-level Commentary by Fiscal Year
| Fiscal year | Country-level commentary (company) |
|---|---|
FY2022 | Italy up about 45% over the first nine months; Romania strong; duty free recovering [S38][S27] |
FY2023 | Slovakia +39%; Italy +12% in value, flat in volume; duty free +52% in value; Romania +6%; Q4 weakness in Romania and Germany [S3] |
FY2024 | Italy +4%; Romania roughly flat; Germany −17%; Slovakia −12% [S23] |
FY2025 | Exports +15.2%, driven by Romania and Slovakia TV campaigns; Italy investment continued [S2][S42] |
FY2026 | Romania and duty free up significantly; Italy, Germany and Slovakia down; total exports −5.1% [S1] |
Q1 FY2027 | Exports −10.4% to HUF 504m. Italy, Germany and Romania down, largely due to forint strength against the euro [S4] |
Share Price History
| Date | Price (HUF) |
|---|---|
Feb 2021 | 16,850 |
Nov 2023 | 17,900 |
Jul 2025 (implied by Simply Wall St market cap of HUF 67.0bn) | about 33500 |
Sep–Oct 2025 (after BUX inclusion news) | about 30800–32000 |
24 Jul 2026 (all-time high) | 40,000 |
6 Aug 2026 | 38,000 |
Approximate Change by Horizon
| Horizon | Approximate change |
|---|---|
1-year (from about HUF 31,000 in Oct 2025) | about +23% |
3-year (from HUF 17,900 in Nov 2023) | about +112% |
5-year (from HUF 16,850 in Feb 2021) | about +126% |
Valuation Multiples
| Multiple | Zwack (at HUF 38,000) | Peer context |
|---|---|---|
Market cap | HUF 76.0bn | — |
Enterprise value (market cap less HUF 3.8bn cash) | HUF 72.2bn | — |
P/E (FY2026 EPS of HUF 1,590) | 23.9x | — |
EV/EBITDA (EBITDA HUF 4,591m) | 15.7x | — |
EV/Sales (revenue HUF 24,432m) | 2.96x (consistent with GuruFocus's 2.94–2.96x) [S17] | — |
P/B (equity HUF 9,145m) | 8.3x | — |
Dividend yield (HUF 1,550) | 4.1% (consistent with GuruFocus's 4.09%) [S17] | — |
P/E on management-implied FY2028 profit (about HUF 2.7bn = 3.18bn × 0.85) | about 28x | Illustrative only |
Per-Share Data and Dividends & Capital Returns
| Metric | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|
Dividend per share for the fiscal year (HUF) | 300 | 700 | 1,500 | 1,700 | 1,400 | 1,500 | 1,550 |
Total dividend declared (HUF Mn) | 600 | 1,400 | 3,000 | 3,400 | 2,800 | 3,000 | 3,100 |
Capital Markets
| Item | Status |
|---|---|
Buyback authorisation | None; no treasury shares held [S4] |
Credit ratings (Moody's / S&P / Fitch) | None; the company is unrated and has no debt |
Debt maturity profile | No borrowings. Lease liabilities of HUF 27m (HUF 6m due within one year, HUF 21m in one to five years). Committed facilities of HUF 7.3bn, maturing 2049–2099 [S1] |
Analyst Conclusions
Management guidance
| Period | Guidance |
|---|---|
| FY2027 (to Mar 2027) | Net profit of about HUF 3.1bn [S8]; no material Diageo impact [S6] |
| FY2028 onward | Profit about 15% below the current level absent offsets [S6]. Implied net profit is about HUF 2.7bn (analyst calculation) |
| Volumes | No significant domestic expansion expected; export-led growth focus [S7] |
Consensus growth expectations: not publicly disclosed.
Bull case
-
Own-brand economics are intact and improving. Own-produced products delivered HUF 1,002m of operating profit in Q1 FY2027 at a margin of about 22%, and gross margin is at a five-year high of 64.6%. Losing a 6%-margin distribution business could leave a leaner, higher-quality earnings base once costs are right-sized [S4][S1].
-
Innovation optionality. The Orange Bitter, Trezor XO, Kalumba RTD and Sült Gesztenye sequence shows a repeatable launch engine. Orange Bitter has not yet been launched abroad, which offers upside to the 10% export base [S7].
-
Freed capacity attracts new principals. Zwack has Hungary's largest spirits sales force and HUF 3.8bn of net cash. A new multinational or independent portfolio could recover a meaningful share of the lost HUF 5.2bn of traded revenue. The 15% profit-hit guidance assumes no offset [S6].
Bear case
-
Scale de-leverage. Traded products, services fees (HUF 949m from Diageo Scotland) and purchasing scale disappear. Operating costs (HUF 20.6bn) are largely fixed in the near term, so the drag could exceed 15% if replacement brands lag [S1][S6].
-
Valuation already rich for a no-growth business. At about 24x trailing and about 28x management-implied FY2028 earnings, with 1.6% revenue growth and flat volumes guided, the stock embeds substantial execution success. Loss of BUX membership reduces passive demand [S10].
-
Structural export failure and regulatory drag. Exports have missed targets for three years and fell 10.4% in Q1 FY2027. Excise has risen in each of 2022, 2025 and 2026. Domestic demand is constrained [S4][S1].
Key catalysts and monitorables (next 12 months)
| Expected timing | Catalyst / monitorable |
|---|---|
| Early Nov 2026 | H1 FY2027 results: marketing spend normalisation after the Q1 deferral; export trend |
| Q4 2026 | Identity of Diageo's new distributor and any knock-on effects on trade terms |
| By 31 Dec 2026 | Fate of the Diageo–PZHG shareholders' agreement; whether Diageo's 26% stake changes hands (unconfirmed) |
| Q4 2026 – Q1 2027 | Announcement of new third-party brand mandates |
| Dec 2026 – Feb 2027 | Christmas-season sell-through, including Sült Gesztenye; nine-month report in early Feb 2027 |
| 1 Jan 2027 | Possible Hungarian excise and NETA changes; start of post-Diageo operations |
| May 2027 | FY2027 results and the first explicit FY2028 guidance post-Diageo; dividend proposal (FY2027 profit of about HUF 3.1bn suggests DPS capacity around HUF 1,500+) |
| Ongoing | Replacement of the departed Board and Supervisory Board members; board independence |
| Ongoing | Share-price reaction to the 23 Sep 2026 news and liquidity after BUX exit |
Analyst verdict
Zwack Unicum enters FY2027 in an unusual position: it is operationally at a cyclical high and strategically at an inflection point. The FY2026 numbers were the best-quality set in four years. Operating profit grew 8.8% on 1.6% revenue growth, gross margin reached a five-year high of 64.6%, and Unicum innovation, led by Orange Bitter, did the heavy lifting. Q1 FY2027 extended that run, although the 22.7% profit growth flatters underlying trends because marketing spend was deferred.
The Diageo decision fundamentally changes the investment case. For 33 years the Diageo mandate gave Zwack scale, a full premium portfolio, fixed-cost absorption, service income and an aligned strategic shareholder. From 1 January 2027 Zwack loses the brands and, potentially over time, the alignment. Management's estimate of about 15% lower profit from FY2028 is credible because traded products contribute far less profit than revenue. Even so, that estimate assumes Zwack can shrink the cost base around a smaller business and avoid losing bargaining power with Hungarian retailers, which are themselves under regulatory pressure.
What remains is a rare asset: a debt-free, high-ROIC heritage brand with a proven launch engine, a committed founding family and the Underberg partnership behind it. The investment debate therefore turns on three variables: how quickly new distribution mandates are signed, whether Unicum can finally become a genuine export brand after years of missed targets, and what Diageo does with its 26% stake.
At the last verified price (HUF 38,000, before the tender loss), the shares discounted near-flawless execution: about 24x trailing earnings, about 16x EV/EBITDA and a 4.1% yield. The post-announcement price must be checked before drawing a valuation conclusion. On fundamentals, our stance is neutral with a quality bias. The franchise is resilient and the dividend is sustainable at a moderately lower level. Upside requires visible progress on replacement brands and exports by the FY2027 results in May 2027. Until then, earnings visibility beyond March 2027 is the lowest it has been in decades.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Title | In role since | Background | Age | Shares held |
|---|---|---|---|---|---|
Csaba Belovai | Chief Executive Officer; Board member | 1 Jul 2025 | Joined Zwack in January 2004 as Commercial Director; Commercial & Export Director from 1 April 2009 [S9] | Born 1970 [S9] | 8,500 liquidation-preference shares [S4] |
György Guttengeber | Deputy CEO & Chief Financial Officer; Board member | 1 Jul 2025 | Responsible for accounting and IFRS reporting [S1]; prior roles not disclosed | — | none disclosed |
Amanda Farkas | Commercial & Export Director | 1 Jul 2025 | Prior roles not disclosed | — | none disclosed |
Beáta Harcsa | Marketing Director | 8 Sep 2022 | Prior roles not disclosed | — | none disclosed |
Orsolya Virágh | Human Resources Director | 1 Aug 2018 | Prior roles not disclosed | — | none disclosed |
Sándor Attila Kocsi | Production & Technical Director | 1 Apr 2025 | Prior roles not disclosed | — | none disclosed |
Executive Leadership Team
| Name | Role | Member since | Mandate to | Notes |
|---|---|---|---|---|
Sándor Zwack | Chair | 26 Jun 2008 | 31 Jul 2029 | Sixth generation of the founding family; also holds a brand-expert role [S4][S32b] |
Wolfgang Spiller | Deputy Chair | 28 Jun 2012 | 31 Jul 2029 | [S4] |
Isabella Veronika Zwack | Member | 26 Jun 2008 | 31 Jul 2029 | Sixth-generation family member [S4] |
Zoltán Hangodi | Member | 29 Jun 2022 | 31 Jul 2028 | [S4] |
Gabriella Harkai-Józsa | Member | 28 Jun 2023 | Resigned effective 30 Sep 2026 | [S4][S13] |
Csaba Belovai | Member (CEO) | 1 Jul 2025 | 31 Jul 2028 | [S4] |
György Guttengeber | Member (Deputy CEO/CFO) | 1 Jul 2025 | 31 Jul 2028 | [S4] |
Board of Directors — Dr. Hubertine Underberg-Ruder
| Name | Role | Member since | Mandate to | Notes |
|---|---|---|---|---|
Dr. Hubertine Underberg-Ruder | Chair; Audit Committee member | 29 Jun 2006 | 31 Jul 2029 | Underberg family, co-ultimate owner [S1][S4] |
Thomas Mempel | Deputy Chair | 30 Jun 2021 | 31 Jul 2027 | [S4] |
Dr. András Szecskay | Member | 30 Sep 1992 | 31 Jul 2029 | Founder of Szecskay Attorneys at Law, the company's legal counsel (related party); holds 651 ordinary shares [S1][S4] |
Mónika Pais | Member | 2 Jul 2026 | 31 Jul 2029 | Elected at the 2026 AGM [S4] |
Dr. György Geiszl | Member | 25 Jun 2020 | Resigned effective 30 Sep 2026 | [S4][S13] |
Frank Odzuck | Member | 1 Jul 2025 | 31 Jul 2028 | Former CEO; holds 16,000 liquidation-preference shares [S4] |
Nándor Szakolczai | Former member | 27 Jun 2020 | Left 1 Jul 2026 | [S4] |
Governance Overview
| Item | FY2025 | FY2026 |
|---|---|---|
Key management short-term benefits (HUF Mn) | 962 | 1,010 |
Social security on key management benefits (HUF Mn) | 49 | 73 |
Liability under the cash-settled liquidation-preference share plan (HUF Mn) | 449 | 467 |
Dividends on liquidation-preference shares expensed (HUF Mn) | 49 | 53 |
Major Shareholders
| Holder | Shares | % of registered capital | % voting rights | Type |
|---|---|---|---|---|
Peter Zwack & Consorten HG (Vienna) | 1,000,001 | 49.14 | 50.00 | Controlling family holding (Zwack and Underberg families) |
Diageo Holdings Netherlands B.V. | 520,000 | 25.55 | 26.00 | Strategic investor |
D & F Financial Services BV | 15,000 | about 0.74 | about 0.75 | Institutional (per Simply Wall St, July 2025 data) |
Dr. András Szecskay | 651 | about 0.03 | about 0.03 | Insider |
OTP Alapkezelő Zrt. | 496 | about 0.02 | about 0.02 | Domestic fund manager (July 2025 data) |
Liquidation-preference holders (managers) | 35000 preference shares | 1.72 | 0.00 | Insiders. These shares carry no AGM voting rights. |
Competitive Landscape
Competitors by Segment
| Segment | Competitor | Ownership / listing | Relative positioning vs Zwack |
|---|---|---|---|
Herbal liqueurs and bitters | Mast-Jägermeister SE (Jägermeister) | Private (Germany) | — |
Herbal liqueurs and bitters | Campari Group (Campari, Averna, Aperol) | Listed, Euronext Milan | Global bitters and aperitif leader; competes in mixology occasions |
Herbal liqueurs and bitters | Fratelli Branca (Fernet-Branca) | Private (Italy) | Niche bitter; competes in Italy, Zwack's largest export market |
Herbal liqueurs and bitters | Becherovka (Jan Becher, Pernod Ricard group) | Part of Pernod Ricard | Regional CEE herbal-bitter peer |
Herbal liqueurs and bitters | Underberg | Private; related party (co-owner of Zwack's parent) | Digestif bitter. Its relationship with Zwack is cooperative rather than competitive |
International spirits portfolios in Hungary | Diageo, via its new distributor from 2027 | Listed (LSE/NYSE) | Moves from partner to competitor; takes Johnnie Walker, Baileys, Smirnoff and others to a rival route-to-market |
International spirits portfolios in Hungary | Pernod Ricard (Jameson, Absolut, Beefeater, Becherovka) | Listed (Euronext Paris) | Major portfolio competitor in whisky, vodka and gin |
International spirits portfolios in Hungary | Bacardi (Bacardi, Bombay Sapphire, Martini) | Private | Rum, gin and vermouth competitor |
International spirits portfolios in Hungary | Brown-Forman (Jack Daniel's) | Listed (NYSE) | American whiskey competitor |
Pálinka and fruit spirits | Agárdi, Gyulai, Panyolai and other craft pálinka producers | Private (Hungary) | Compete with Vilmos, Fütyülős and Zwack pálinkas |
Pálinka and fruit spirits | Untaxed home and contract-distilled pálinka | Informal / legal home distilling | Management has cited it historically as a structural drain on the taxed market [S46] |
Gin | Gordon's and Tanqueray (Diageo), Beefeater (Pernod), Bombay (Bacardi) | Multinationals | Kalumba competes head-on; management claims segment leadership [S2] |
Peer Comparison FY2026
| Metric | Zwack Unicum (FY to Mar 2026) | Diageo (FY to Jun 2026) | Pernod Ricard (FY to Jun 2026) | Campari Group (FY to Dec 2025) |
|---|---|---|---|---|
Net sales (local currency) | HUF 24.4bn (about EUR 63m at roughly HUF 385/EUR, analyst conversion) [S1] | USD 19,643m [S21] | EUR 9,404m [S22] | EUR 3.05bn [S20] |
Reported growth | +1.6% | −3.0% (organic −2.0%) | −14.2% (organic −3.9%) | −0.6% (organic +2.4%) |
Operating margin | 16.0% (reported EBIT) | 16.1% reported; 28.9% before exceptionals | 25.8% (profit from recurring operations EUR 2,423m / sales; analyst calculation) | 20.9% (adjusted EBIT) |
EBITDA margin | 18.8% (analyst calculation) | — | — | 25.7% (adjusted) |
Net margin | 13.0% | 10.0% (USD 1,958m / USD 19,643m; analyst calculation) | — | 11.3% (EUR 346m reported / EUR 3.05bn; analyst calculation) |
Leverage (net debt / EBITDA) | Net cash, −0.83x | — | — | 2.5x [S20] |
Recent Developments
The winning bidder in the Diageo tender had not been publicly identified in the sources reviewed as of 18 October 2026.



